v3.24.1.u1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   631      
Beginning balance at Dec. 31, 2022 $ 5,560 $ 0 [1] $ 11,557 $ (32) $ (5,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 117       117
Other comprehensive income 2     2  
Exercise of common stock options (in shares)   2      
Exercise of common stock options 17   17    
Issuance of common stock upon settlement of RSUs, net of shares withheld for taxes (in shares)   1      
Issuance of common stock upon settlement of RSUs, net of shares withheld for taxes (155)   (155)    
Stock-based compensation 243   243    
Repurchases of common stock (in shares)   (4)      
Repurchases of common stock (493)       (493)
Ending balance (in shares) at Mar. 31, 2023   630      
Ending balance at Mar. 31, 2023 5,291 $ 0 [1] 11,662 (30) (6,341)
Beginning balance (in shares) at Dec. 31, 2023   638      
Beginning balance at Dec. 31, 2023 8,165 $ 0 [1] 11,639 (49) (3,425)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 264       264
Other comprehensive income $ 40     40  
Exercise of common stock options (in shares) 1 1      
Exercise of common stock options $ 46   46    
Issuance of common stock upon settlement of RSUs, net of shares withheld for taxes (in shares)   2      
Issuance of common stock upon settlement of RSUs, net of shares withheld for taxes (168)   (168)    
Stock-based compensation 302   302    
Repurchases of common stock (in shares)   (5)      
Repurchases of common stock (753)       (753)
Ending balance (in shares) at Mar. 31, 2024   636      
Ending balance at Mar. 31, 2024 $ 7,896 $ 0 [1] $ 11,819 $ (9) $ (3,914)
[1] Amounts round to zero and do not change rounded totals